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The vesicular transmitter transporters VGLUT, VGAT, VMAT2 and VAChT, define
phenotype and physiological properties of neuronal subtypes. VGLUTs concentrate
the excitatory amino acid glutamate, VGAT the inhibitory amino acid GABA, VMAT2
monoamines, and VAChT acetylcholine (ACh) into synaptic vesicle (SV). Following
membrane depolarization SV release their content into the synaptic cleft. A strict
segregation of vesicular transporters is mandatory for the precise functioning of synaptic
communication and of neuronal circuits. In the last years, evidence accumulates that
subsets of neurons express more than one of these transporters leading to synaptic
co-release of different and functionally opposing transmitters and modulation of synaptic
plasticity. Synaptic co-existence of transporters may change during pathological
scenarios in order to ameliorate misbalances in neuronal activity. In addition, evidence
increases that transporters also co-exist on the same vesicle providing another layer of
regulation. Generally, vesicular transmitter loading relies on an electrochemical gradient
∆µH+ driven by the proton ATPase rendering the lumen of the vesicle with respect
to the cytosol positive (∆ψ) and acidic (∆pH). While the activity of VGLUT mainly
depends on the ∆ψ component, VMAT, VGAT and VAChT work best at a high ∆pH.
Thus, a vesicular synergy of transporters depending on the combination may increase
or decrease the filling of SV with the principal transmitter. We provide an overview
on synaptic co-existence of vesicular transmitter transporters including changes in
the excitatory/inhibitory balance under pathological conditions. Additionally, we discuss
functional aspects of vesicular synergy of transmitter transporters.
Keywords: vesicular transmitter transporters, synaptic co-existence, vesicular synergy, glutamate, GABA
Abbreviations: ACh, acetylcholine; AMPA, alpha-amino-3-hydroxy-5-methyl-4-isoxacole propionic acid; ChAT, choline
acetyltransferase; cKO, conditionally knocked out; CNS, central nervous system; EPSC, excitatory postsynaptic current;
GAD65/67, glutamate decarboxylase; GAT, plasma membrane GABA transporter; GlyT, plasma membrane glycine
transporter; IPN, interpeduncular nucleus; MF/MFT, mossy fiber/mossy fiber terminal; mGluR, metabolic glutamate
receptor; Na+/Pi, transport sodium-phosphate transport; NMDA, N-methyl-D-aspartate; POMC, pro-opiomelanocortin;
SLC, solute carrier; SV, synaptic vesicle; VNT, vesicular neurotransmitter transporter; VAChT, vesicular acetylcholine
transporter; VGAT/VIAAT, vesicular GABA/inhibitory amino acid transporter; VGLUT, vesicular glutamate transporter;
VMAT, vesicular monoamine transporter; 1µH+, electrochemical gradient; 1ψ, electrical gradient; 1pH, proton
gradient.
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INTRODUCTION
Synaptic vesicles (SV) are key organelles for neuronal
communication. They concentrate neurotransmitters produced
in neural cytoplasm. Following presynaptic depolarization,
cytosolic Ca2+ increases and SV release their content by
exocytotic membrane fusion into the synaptic cleft. Fused SV
are retrieved by endocytosis mainly following the clathrin-
mediated pathway. In neurons, specific sets of secondary
active solute transporters are responsible for filling SV
with neurotransmitters. These vesicular neurotransmitter
transporters (VNTs) differ from transporters in the plasma
membrane with respect to energy coupling, substrate specificity
and affinity. Three VNT gene families (solute carrier) comprise
vesicular transporter for amines (SLC18; Schuldiner et al., 1995),
for inhibitory (SLC32; McIntire et al., 1997; Sagné et al., 1997)
and for excitatory amino acids (SLC17; Bellocchio et al., 2000;
Takamori et al., 2000). Members account for the vesicular
transport of monoamines (VMAT1 and VMAT2; SLC18A1,
SLC18A2, respectively), acetylcholine (VAChT, SLC18A3),
GABA/glycine (VGAT also known as VIAAT, SLC32A1),
and glutamate (VGLUT1-3; SLC17A7, SLC17A6, SLC17A8,
respectively). The VNTs specify the quality and quantity of
SV transmitter content and thus the synaptic dynamics of
neurotransmission.
With the avenue of the molecular characterization of
the various VNTs, their distribution in brain areas at the
cellular and subcellular level has been extensively investigated.
Evidence accumulated that different types of VNTs can be
expressed in the same axon terminal resulting in synaptic
co-release of transmitters of opposing function like glutamate
and GABA. In addition, subpopulations of SV harbor not only
one type of VNT. Both, synaptic co-existence and vesicular
synergy of VNTs differently affect synaptic plasticity under
healthy conditions and if misbalanced may lead to various
pathologies.
SYNAPTIC CO-EXISTENCE OF
NEUROTRANSMITTERS AND VNTs
Dale’s principle that one neuron stores and releases only a single
type of neurotransmitter can no longer be maintained in its
strict sense. Before, neuropeptides as well as ATP have been
shown to released together with acetylcholine (ACh), GABA,
and monoamines (for review, see Edwards, 2007). First direct
functional evidence against this principle was the demonstration
of co-release of GABA and glycine from same spinal cord
synapses (Jonas et al., 1998). In this system, however, both
neurotransmitters share the same transporter VGAT/VIAAT.
Studies during the last decades then demonstrated that
especially glutamate could be released together with other
classical neurotransmitters. Glutamate released from cholinergic
spinal cord motor neurons stimulates Renshaw cells and other
motor neurons (Nishimaru et al., 2005). The co-release of
excitatory glutamate and inhibitory GABA neurotransmitters
has been controversially discussed (Gutiérrez et al., 2003;
Uchigashima et al., 2007). However, a variety of investigations
including the differential synapse-specific co-existence of
VGLUT1 and VGLUT2 with VGAT (Zander et al., 2010 see
below) indicate that co-release of glutamate and GABA is more
widespread than previously anticipated (Seal and Edwards,
2006; Chaudhry et al., 2008; El Mestikawy et al., 2011). Such
co-release may not necessarily result in a direct antagonism
but represents a new layer of fine-tuning synaptic networks.
Following scenarios may apply to synaptic co-existence and
co-release : (1) The VNTs reside on distinct populations of SVs
in the axon terminal, indicating the potential for different release
at distinct sites, which then activate subsets of postsynaptic
receptors (Figure 1). This principle may primarily apply to
giant terminals containing many transmitter release sites
such as the mossy fiber terminals (MFTs; Boulland et al.,
2009). (2) A spatial selective distribution of neurotransmitter
receptors and their different affinities as well as variations
in the type of synapses modulate the controlled activation of
pre- and postsynaptic receptors (Rubio and Wenthold, 1997)
depending on different transmitters released by a common site
(Figure 1).
Three isoforms of VGLUTs (VGLUT1, VGLUT2 and
VGLUT3) mediate the vesicular uptake of glutamate in central
nervous system (CNS) neurons thereby defining glutamatergic
neurotransmission. VGLUTs share salient structural and
functional characteristics but differ in cellular localization
and trafficking, suggesting isoform-specific physiological roles
beyond their primary role of concentrating glutamate into SV
(Fremeau et al., 2004; Chaudhry et al., 2008). In CNS, VGLUT1
and VGLUT2 show complementary patterns of expression
mainly in subset of glutamatergic neurons (Fremeau et al.,
2001; Varoqui et al., 2002). VGLUT3, by contrast, is mainly
expressed in non-glutamatergic neurons characterized by other
neurotransmitters (Fremeau et al., 2002; Gras et al., 2002;
Takamori et al., 2002). In addition, VGLUT1 and VGLUT2
have been shown to be co-expressed in various subsets of
non-glutamatergic neurons (Trudeau, 2004; Danik et al., 2005;
Kawano et al., 2006), further supporting the idea that glutamate
also acts as a co-transmitter.
For the inhibitory transmitters GABA and glycine only one
transporter VIAAT/VGAT has been identified (McIntire et al.,
1997; Sagné et al., 1997) which transports the two transmitters
into SV with comparable uptake characteristics (Christensen and
Fonnum, 1991). The genetic deletion of VGAT in mice finally
proved, that VGAT is the only transporter for both inhibitory
transmitters (Wojcik et al., 2006). VGAT is co-expressed with
either the GABA-synthesizing enzymes glutamate decarboxylase
(GAD65 and 67), as well as the plasma membrane GABA
transporter GAT1 or the plasma membrane glycine transporter
GlyT2, (Sagné et al., 1997; Chaudhry et al., 1998; Dumoulin et al.,
1999; Dalby, 2003; Dufour et al., 2010), respectively. Thereby the
GABAergic (Wojcik et al., 2006) or glycinergic (Gomeza et al.,
2003) phenotype of neurons is defined.
Glutamate is the main excitatory neurotransmitter
released from hippocampal MFTs (Crawford and Connor,
1973; Storm-Mathisen et al., 1983; Terrian et al., 1988;
Bramham et al., 1990). For long, it has been known that
also the inhibitory GABA transmitter is present in MFTs
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FIGURE 1 | Synapse-specific co-existence of VGLUT and VGAT. (A) Hippocampal mossy fiber terminals (mft) of the CA3 area or cerebellar basket cell terminals
(cbt) were double immunolabeled with antisera against either VGLUT1 (rabbit 5 nm gold) and VGAT (guinea pig, 10 nm gold particles) or against VGAT (guinea pig,
10 nm gold particles) and against VGLUT2 (rabbit, 5 nm gold particles), respectively (Zander et al., 2010). Distinct SV associated gold particles either indicating
VGLUT are marked in insert by forked arrowheads or indicating VGAT by triangles. (B) Quantification of the number of gold particles staining for VGLUT1, VGLUT2
and VGAT in glutamatergic and GABAergic terminals of the hippocampal CA3 area and of the cerebellum (see Zander et al., 2010). (C) Scheme depicting the
variations involved in synaptic co-existence of VNTs of opposing function (blue-VGLUT, green-VGAT) in the same vesicle and in different vesicle populations with
distinct (above) or combined (below) release sites (orange labeled) within axon terminal. pd, pyramidal dendrite; sp, spine; pc, purkinje cell body; m, mitochondria;
thin arrows indicate asymmetric contacts, thick open arrows indicate symmetric contact. Bars given in (A) represent 200 nm.
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(Sandler and Smith, 1991; Sloviter et al., 1996). A final
confirmation demands that GABA: (1) occurs in SVs
of MFTs; (2) is released in response to stimulation; and
(3) produces specific receptor responses. To support the idea
of the dual glutamatergic-GABAergic phenotype of MFTs,
we performed quantitative postembedding immunogold
labeling with antibodies specific to VGLUTs and VGAT at the
electron microscopic (EM) level. Postembedding immunogold
EM is the method of choice to label precisely subcellular
organelles, such as SV (Bergersen et al., 2008; Grønborg
et al., 2010; Zander et al., 2010; Ormel et al., 2012). By this
method, a synaptic co-localization of VGLUTs and VGAT
in glutamatergic hippocampal and cerebellar MFTs could be
demonstrated (Figure 1). The specificity of the co-existence
of VGAT with VGLUT in MFTs (Figure 1) is underscored
by the complete absence of VGAT immunoreactivity in
other glutamatergic terminals such as cerebellar parallel
(VGLUT1-positive) and climbing (VGLUT2-positive) fiber
terminals identified in the same section (Figure 1). These
findings provide a strong morphological evidence for synaptic
co-existence of glutamate and GABA in adult glutamatergic
MFTs under healthy conditions. In a similar approach, it
was shown, that GABA is present together with glutamate
in large MFTs and that both amino acids were associated
with distinct SV (Bergersen et al., 2003, 2008). However,
GABAergic synaptic transmission at MFTs requires the presence
of postsynaptic GABA receptors. Indeed, GABAA receptors
appear to co-localizes, with glutamate alpha-amino-3-hydroxy-
5-methyl-4-isoxazole propionic acid (AMPA) receptors, in
postsynaptic densities in close apposition to MFTs (Bergersen
et al., 2003). Their additional presynaptic contributing add
to subthreshold electrical signaling in hippocampal MF (Alle
and Geiger, 2007). This finding strongly suggests that MFs
may convey not only a glutamatergic but also a GABAergic
signal to their targets (Gutiérrez, 2005). Consistent with this
hypothesis, monosynaptic GABAergic currents have been
recorded in CA3 principal cells upon granule cell stimulation
in the dentate gyrus in acute hippocampal slices from new-born
(Safiulina et al., 2006) or juvenile animals (Walker et al., 2001;
Gutiérrez et al., 2003). The evoked responses fulfil the criteria
for identification of GABAergic MF inputs: strong, paired pulse
facilitation, short-term frequency dependent facilitation, and
sensitivity to group II and III mGluR agonists (Safiulina et al.,
2006).
Several lines of evidence indicate that overshooting
glutamatergic transmission play a key role in the ethology
and progression of temporal lobe epilepsy (During and Spencer,
1993; Petroff et al., 2002; Cavus et al., 2005; El-Hassar et al.,
2007). An increased expression of VGLUT may be important
in the initiation and/or maintenance of seizures as shown in
different animal models for epilepsy. Remarkably, treatment
with antiepileptic drugs reduced VGLUT1 overexpression and
seizure activity (Kang et al., 2005, 2006; Kim et al., 2005).
In addition, a change in the balance between glutamatergic
(VGLUT) and GABAergic (VGAT) expression in MFTs of the
hippocampus appears to be crucial during the development of
overexitation (Gomez-Lira et al., 2005).
In recent years, optogentic studies using the targeted
expression of channel rhodopsin and modifications thereof
yielded new insight in themechanisms how different transmitters
released from the same terminal may affect neurotransmission
and behavior (Jiang et al., 2014; Trudeau et al., 2014).
For example, optogenetic stimulation of arcuate hypothalamic
neurons expressing diverse neuropeptides derived from pro-
opiomelanocortin (POMC) leads to release of either glutamate
or GABA causing fast postsynaptic actions (Dicken et al., 2012).
Optogenetically labeled mesolimbic dopaminergic neurons
were shown to release glutamate in the nucleus accumbens
(Tecuapetla et al., 2010; Chuhma et al., 2014). In turn,
habenula-derived cholinergic neurons release glutamate during
brief optogenetic stimulation of their axons, and release ACh
during stronger and more prolonged stimulation (Ren et al.,
2011). Further examples are the regulation of spontaneous
locomotor activities likely modulated by glutamate released
from cholinergic interneurons in the striatum (Guzman et al.,
2011). Using an optogenetic approach the relative importance
of ACh released alone vs. ACh plus a co-released additional
transmitter could be also distinguished. In this context, it
has been shown that amacrine cells in the retina co-release
ACh and GABA by distinct SV populations (Lee et al.,
2010).
VESICULAR SYNERGY OF VNTs
Vesicular co-existence at the synaptic level also includes
vesicular synergy. Vesicular synergy involves the presence of
VNTs, which differ in their dependance on the electrochemical
gradient including the co-storage of transmitters with opposing
function (El Mestikawy et al., 2011). Generally, all VNTs
rely on the vesicular VoATPase that pumps H+ ions into
the SV and builds up an electrochemical gradient (∆µH+)
rendering the vesicular lumen with respect to the cytosol
positive (∆ψ) and acidic (∆pH). The various VNTs differ in
their preference for either ∆pH or ∆ψ. VAChT and VMAT
strongly depend on the ∆pH component. In contrast, VGLUT
and VNUT (vesicular nucleotide transporter) appear to work
best at a high ∆ψ. Using purified VGLUT1 reconstituted
with an exogenous proton pump in liposomes, liposome-fused
and native SV, the ∆ψ-dependance, chloride transport and
H+/K+ exchange activity of VGLUT have been demonstrated
(Schenck et al., 2009; Preobraschenski et al., 2014). For
VGAT there is presently no agreement about the transport
mechanism by which the inhibitory transmitters GABA and
glycine are concentrated into SV, with a proton exchange
and chloride-cotransport mechanism being discussed (Burger
et al., 1991; Juge et al., 2009). The presence of different
VNTs on a single SV implies that the loading of the
basic transmitter is modulated by the additional transport of
a second transmitter, which improves either ∆pH or ∆ψ
depending on the combination. In this respect, the most
frequent combinations involve VGLUT (one of the three
isoforms) in either monoaminergic, cholinergic or GABAergic
neurons. VGLUT depends on ∆ψ and VMAT/VAChT or
VGAT exclusively or partially rely on ∆pH, respectively.
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FIGURE 2 | Functional impact of vesicular co-existence. (A) Nigericin (500 nM) increases glutamate uptake into rat brain SV, while the uptake of serotonin or
GABA is inhibited. Values are presented as percent of uptake in the absence of nigericin (control) and represent mean and SD of six samples obtained in two different
experiments (see also Preobraschenski et al., 2014). Nigericin promotes H+/K+ exchange thereby decreasing ∆pH with no or small effects on ∆ψ. This favors
VGLUT activity while both VGAT and VMAT activity are reduced or dissipated, respectively. (B) Immunoisolation of SV populations was performed from whole
(Continued)
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FIGURE 2 | Continued
rat brain with or without the antibodies indicated. A standard curve from the
starting material (LS0) was run in parallel to calculate the respective protein
amounts in the individual immunoisolates (Zander et al., 2010). (C) Glutamate
increases the vesicular uptake of either serotonin or GABA into rat brain SV.
Uptake in the absence of glutamate was set to 100%. Values represent the
mean and SD of four samples obtained in two experiments (modified from
Zander et al., 2010). Each transported glutamate molecule increases ∆pH
thereby improving VGAT and VMAT activity. (D) Glutamate uptake into SV
prepared from rat interpeduncular nucleus (IPN) is increased in the presence
of acetylcholine (ACh). Values are expressed as pmoles/mg protein and were
obtained from four different experiments (Frahm et al., 2015). The positively
charged ACh like NH+4 , decreases ∆pH and slightly increases ∆ψ, thereby
improving VGLUT activity (see also Preobraschenski et al., 2014). ∗p < 0.05
Student’s t-test.
The opposing effects of ∆pH for transmitter filling becomes
obvious when monoamine, glutamate or GABA uptakes are
performed in the presence of nigericin. Nigericin exchanges
H+ against K+ thereby dissipating ∆pH with negligible
effects on ∆ψ. Consequently, nigericin almost abolishes
serotonin and partially inhibits GABA uptake but promotes
vesicular filling with glutamate (Preobraschenski et al., 2014;
Figure 2).
Using immunoisolation the vesicular synergy of VGLUT2
and VMAT2 has been identified in SV preparations from rat
striatum (Hnasko et al., 2010). This vesicular synergy improves
the monoamine filling in the presence of glutamate since each
transported glutamate has to be compensated by a proton,
which increases ∆pH and supports VMAT activity (Hnasko
et al., 2010; Zander et al., 2010; Figure 2). Consequently,
tissue levels of dopamine are decreased in the ventral striatum
following deletion of VGLUT2. At the behavioral level, VGLUT2
deletion in striatal dopaminergic neurons reduces motor activity
following cocaine treatment (Hnasko et al., 2010). VGLUT3
appears to occur preferentially in 5-HT neurons. These neurons
also rely on VMAT2 for concentrating serotonin into SV.
Comparable to the VGLUT2/VMAT2 combination in the
striatum the absence of VGLUT3 causes an anxiety-related
behavior in the mutants probably due to the reduced filling in
subsets of serotonergic SV (Amilhon et al., 2010; see also Figure 2
and Zander et al., 2010).
All three VGLUT isoforms appear to be associated with
various subpopulations of GABAergic SV. In rat cerebral
cortex, immunoisolation revealed VGLUT1 but not VGLUT2
as co-existing on VGAT SV (Fattorini et al., 2009). Overall
brain, vesicular synergy appears to involve VGLUT2 or
VGLUT3 as dominant partners for VGAT SV (Seal et al.,
2008; Grønborg et al., 2010). Immunoisolations from whole
brain post nuclear fractions using either VGLUT1, VGLUT2
or VGAT antibodies support this notion with a preference
of VGAT on VGLUT2 over VGLUT1 SV and vice versa
(Zander et al., 2010; Figure 2). Irrespective of the VGLUT
isoform, VGLUT/VGAT synergy may functionally improve
vesicular filling with GABA in GABAergic vesicles and fine-
tune the excitatory/inhibitory balance. Indeed vesicular GABA
filling is enhanced in the presence of glutamate (Figure 2;
Zander et al., 2010). As with VMAT, the negatively charged
glutamate increases ∆pH thereby promoting VGAT activity.
The functional impact for vesicular GABA loading is evident
in VGLUT3 deletion mutants, which besides their deafness also
suffer from rare seizures. As an additional explanation, the
lack of glutamate co-release from subpopulations of GABAergic
neurons may cause a hyper-synchronization of GABAergic
interneurons (Ahnert-Hilger and Jahn, 2008). In the same
line, the vesicular synergy of VGLUT1 on VGAT SV has
been reported to fine tune an excitation/inhibition balance
in cortical microcircuits (Fattorini et al., 2015). VGLUT, in
particular VGLUT3 in the striatum and raphe nucleus of
adult is targeted to cholinergic and serotonergic vesicles where
it synergizes the action of vesicular transporters for ACh
and serotonin, increasing both rate and degree of vesicle
filling (Gras et al., 2008; Amilhon et al., 2010; for review
El Mestikawy et al., 2011). Deletion of VGLUT3 besides
the above mentioned effects in GABAergic neurons (Seal
et al., 2008) causes motor hyperactivity and an increased
sensitivity to cocaine explained by the reduced vesicular
storage of ACh in striatal cholinergic SV (Gras et al.,
2008).
A synaptic and vesicular coexistence between VGLUT1
and VAChT has been also identified in cholinergic neurons
projecting from the median habenula to the interpeduncular
nucleus (IPN). These neurons exhibit robust glutamatergic
transmission involving AMPA and NMDA-receptor EPSCs in
addition to slow nicotinic ACh-mediated currents (Ren et al.,
2011). While this appears to extend the promoting effects of
VGLUT on ACh filling mediated by ∆pH-dependent VAChT
(see above), it was recently reported that in these neurons
ACh promotes vesicular glutamate filling. Using conditionally-
knocked out (cKO) mice with choline acetyltransferase (ChAT)
being selectively deleted in median habenula neurons it turned
out that EPSCs are reduced while the median habenula/IPN
projections are perfectly equipped with VGLUT1/VGLUT2
and VAChT. The cKo–ChAT mice show reduced EPSCs and
are completely insensitive to nicotine-conditioned reward and
withdrawal. The findings are best explained by the lack in
production and vesicular filling of ACh in the highly VGLUT
expressing vesicles. ACh is a weak base, can transiently increase
the luminal pH (which decreases the ∆pH) and promotes
glutamate uptake (Frahm et al., 2015; Figure 2) comparable to
NH+4 (Preobraschenski et al., 2014).
Taken together vesicular synergy represents the modulation
of vesicular filling with one transmitter by changing either ∆pH
or ∆ψ by a second transmitter (see above). As an exception,
the broad co-existence between VGLUT1 and VGLUT2 (Herzog
et al., 2006; Grønborg et al., 2010; Zander et al., 2010) probably
does not change vesicular glutamate filling with both isoforms
exhibiting similar kinetic properties. However, VGLUT1 but not
VGLUT2 interacts with endophilin. This interaction changes the
sorting behavior of VGLUT1 expressing SV (Voglmaier et al.,
2006) and modulates their release probability (Weston et al.,
2011). Thus, co-existence of VGLUT1 and VGLUT2 on the same
vesicle may differentially affect endocytic retrieval modulating
the persistence of VGLUTs at the plasma membrane where the
transporters may be involved in Na+/Pi transport. Such changes
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in plasma membrane vs. SV associations appear to be relevant
in context of a day/night cycle (Yelamanchili et al., 2006; Darna
et al., 2009).
CONCLUDING REMARKS AND FUTURE
PERSPECTIVES
VNTs define the transmitter phenotype of SV and neurons and
their overall expression is strictly segregated. However, there
are layers of modulation at the synaptic or SV level: (1) Some
neurons equip their nerve terminals with VNTs transporting
transmitter of opposing or different function. This synaptic co-
existence increases the functional diversity in between aminergic,
GABAergic and glutamatergic neuron types. (2) Different VNTs
populate the same SV in some terminals thereby modulating
synaptic activity elicited by the main principal transmitter of
these neurons. Examples are the vesicular synergy of VGLUT
with either VGAT, VAChT, or VMAT, respectively.
Additional layers of modulation refer to the putative GABA
transport by VMAT in dopaminergic neurons (Tritsch et al.,
2012). Accordingly, the different endocytic retrieval of VGLUT
isoforms and the transient expression of VGLUT1 at the plasma
membrane also differentially shapes synaptic activity in a diurnal
context. Besides glutamatergic neurons, this may also apply to
neurons where VGLUT1 coexists at either the synaptic or the SV
level.
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